Number of shares and votes in Active Biotech>
Number of shares and votes in Active Biotech
(Thomson Reuters ONE) - The number of shares and votes in Active Biotech has changed as aconsequence of the recently completed rights issue with pre-emptiverights for the shareholders.Today, the last trading day of the month, there are in total64,052,238 shares and votes in Active Biotech.Lund, June 30, 2009Active Biotech AB (publ)For further information, please contact:Hans Kolam, CFOTel: +46 (0)46 19 20 44E-mail: hans.kolam(at)activebiotech.comAbout Active BiotechActive Biotech AB (NASDAQ OMX NORDIC: ACTI) is a biotechnologycompany with focus on autoimmune/inflammatory diseases and cancer.Projects in pivotal phase are laquinimod, an orally administeredsmall molecule with unique immunomodulatory properties for thetreatment of multiple sclerosis, as well as ANYARA for use in cancertargeted therapy, primarily of renal cancer. Further key projects inclinical development comprise the three orally administered compoundsTASQ for prostate cancer, 57-57 for SLE and RhuDex(TM) for RA. Pleasevisit www.activebiotech.com for more information.Active Biotech ABPO Box 724, SE-220 07 LundSwedenTel: +46 (0)46-19 20 00Fax: +46 (0)46-19 11 00Active Biotech is required under the Financial Instruments TradingAct to make the information in this press release public. Theinformation was submitted for publication at 08:30 am CET on June 30,2009.This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
" alt="Half-yearly report>
">
" alt="Huhtamaki sells expanded polystyrene packaging business in Australia>
">
Datum: 30.06.2009 - 02:30 Uhr
Sprache: Deutsch
News-ID 1002401
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
London
Phone:
Kategorie:
Business News
Anmerkungen:
Diese Pressemitteilung wurde bisher 423 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Number of shares and votes in Active Biotech>
"
steht unter der journalistisch-redaktionellen Verantwortung von
Active Biotech (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
